HTT-D3
HTT-D3 is a potent and orally active huntingtin (HTT) splicing modulator. HTT-D3 acts by promoting the inclusion of a pseudoexon containing a premature termination codon (stop-codon psiExon), leading to HTT mRNA degradation and reduction of HTT levels. HTT-D3 reduces p-glycoprotein (P-gp) efflux, and can be uesd for Huntington's disease research[1].
Product Specifications
CAS Number
2254502-89-9
UNSPSC
12352005
Target
P-glycoprotein
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/htt-d3.html
Solubility
10 mM in DMSO
Smiles
FC1=CC(C2=NN3C(C(C)=C2)=NC(C)=C3)=CC4=NN=C(C5CCN(CC)CC5)C=C14
Molecular Formula
C23H25FN6
Molecular Weight
404.48
References & Citations
[1]Anuradha Bhattacharyya, et al. Small molecule splicing modifiers with systemic HTT-lowering activity. Nat Commun. 2021 Dec 15;12 (1) :7299.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Browse additional items from our catalog
Metadherin (MTDH, 3D3, 3D3/LYRIC, AEG1, AEG-1, Astrocyte elevated gene-1 protein, LYRIC, LYRIC/3D3, Lysine-rich CEACAM1 co-isolated protein, Metastasis adhesion protein, Protein LYRIC) (APC)
Metadherin (MTDH, 3D3, 3D3/LYRIC, AEG1, AEG-1, Astrocyte elevated gene-1 protein, LYRIC, LYRIC/3D3, Lysine-rich CEACAM1 co-isolated protein, Metastasis adhesion protein, Protein LYRIC) (APC)
